Meet Joey

"In my early years, on-demand treatment of bleeding episodes was good enough. But as I got older, I learned that serious issues, like joint bleeds, could occur without me even knowing it. As my treatment needs were changing, I realized that treating prophylactically was a better and more comprehensive approach for my well-being. I switched to prophylaxis treatment and was very pleased with my results.

Over the years, I continued researching treatments and having discussions with my doctor. This eventually led me to ALTUVIIIO, the treatment I use today. I learned that ALTUVIIIO was shown to have higher-for-longer factor levels in the near-normal to normal range for most of the week.

These high sustained factor levels interested me because the data showed they were associated with lower risk of bleeds. ALTUVIIIO also showed a 48-hour half-life in adults, which meant I would only have to infuse once a week for prophylaxis.

That infusion schedule meant the world, especially considering my comprehensive treatment experience. Infusing once a week is a massive improvement for me-something I would never have thought possible years ago."

Joey is a promotional speaker compensated by Sanofi.